Inflammatory Outcomes of COVID-19, Post-Complication Disorders, and Related Factors that Could Affect the Intensity of COVID-19
Background: Coronavirus disease 2019 (COVID-19) is an infectious disease that has surrounded the world caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease is usually onset with symptoms like fever, cough, fatigue, respiratory problems, and loss of smell and taste....
Main Authors: | Kasra Jahankhani, Nariman Mosaffa |
---|---|
Format: | Article |
Language: | English |
Published: |
Shahid Beheshti University of Medical Sciences
2023-03-01
|
Series: | Novelty in Biomedicine |
Subjects: | |
Online Access: | https://journals.sbmu.ac.ir/nbm/article/view/40136 |
Similar Items
-
Assessment of Tocilizumab (Humanized Monoclonal Antibody) for Therapeutic Efficacy and Clinical Safety in Patients with Coronavirus Disease (COVID-19)
by: Sami Ullah, et al.
Published: (2022-08-01) -
Pectoral muscle hematoma as a complication of Covid-19 treatment: A Case Report
by: Yıldız Okuturlar, et al.
Published: (2021-03-01) -
Spontaneous hyphema in the setting of COVID-19 pneumonia
by: Joey Chiang, et al.
Published: (2022-06-01) -
Hematological disorders as a complication of COVID-19
by: Yu.I. Markov, et al.
Published: (2023-10-01) -
Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity
by: E. L. Nasonov, et al.
Published: (2020-09-01)